LeMaitre Regains Five CE Marks
|Product||Notified Body||Expiration Date|
|XenoSure Biologic Patches||TUV SUD|
|AlboGraft Polyester Vascular Grafts||TUV SUD|
|Pruitt Carotid Shunts||SGS|
|Flexcel Carotid Shunts||SGS|
|AnastoClip Closure Systems||SGS|
The indications for use under the new CE mark for XenoSure no longer include neuro or cardiac applications, indications for which the product was approved under its prior CE mark. Additionally, only XenoSure made from bovine pericardium sourced from certain of our suppliers is permitted to be sold under the new CE mark.
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon.
LeMaitre is a registered trademark of LeMaitre Vascular, Inc. This press release may include other trademarks and trade names of the Company.
For more information about the Company, please visit http://www.lemaitre.com.
Sandra Millar LeMaitre Vascular, Inc.+1-781-425-1686 email@example.com
Source: LeMaitre Vascular, Inc.